Results 151 to 160 of about 13,763 (191)

Bone Mineral Density After Transitioning From Denosumab to Alendronate

Journal of Clinical Endocrinology and Metabolism, 2020
David Kendler, Patricia Clark, Peter Ebeling   +2 more
exaly  

Alendronate

2011
openaire   +2 more sources

II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women

Endocrine Reviews, 2002
Peter Tugwell, Dennis Black, Andrew Willan   +2 more
exaly  

Alendronate

2007
openaire   +1 more source

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Clinical Therapeutics, 2002
E Michael Lewiecki
exaly  

Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension

Journal of Bone and Mineral Research, 2004
Douglas Bauer, Dennis Black
exaly  

Clinical pharmacology of alendronate sodium

Osteoporosis International, 1993
B K Matuszewski, B J Gertz
exaly  

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

Journal of Bone and Mineral Research, 2007
Douglas Bauer, Steven Cummings
exaly  

Alendronate

2017
openaire   +2 more sources

Alendronic acid/alendronic acid/colecalciferol

Reactions Weekly, 2016
openaire   +1 more source